Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1657 1678 1682
This examiner grants 43% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17293678 | MOLECULES AND METHODS FOR IMPROVED IMMUNODETECTION OF SMALL MOLECULES SUCH AS HISTAMINE | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 17439092 | COMPOSITIONS AND METHODS FOR DIAGNOSING ACUTE INFECTIOUS PERITONITIS | Final Rejection | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 18012798 | PROGNOSIS OF CHRONIC INFLAMMATORY DEMYELINATING POLY-NEUROPATHY | Non-Final OA | Katholieke Universiteit Leuven |
| 17763824 | METHODS OF PRODUCING ANTIBODY COMPOSITIONS | Final Rejection | AMGEN INC. |
| 17488649 | SPR-BASED BINDING ASSAY FOR THE FUNCTIONAL ANALYSIS OF MULTIVALENT MOLECULES | Non-Final OA | Hoffmann-La Roche Inc. |
| 17760692 | DUAL CAPTURE METHOD FOR ANALYSIS OF ANTIBODY-DRUG CONJUGATES | Final Rejection | BRISTOL-MYERS SQUIBB COMPANY |
| 17618869 | TARGETS AND METHODS OF DIAGNOSING, MONITORING AND TREATING FRONTOTEMPORAL DEMENTIA | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 17622037 | COMPOSITIONS AND METHODS FOR LYME DISEASE | Final Rejection | The Johns Hopkins University |
| 19111956 | IMMUNOASSAY FOR DETECTING BIOLOGICALLY ACTIVE PROTEINS | Non-Final OA | PHAEOSYNT GMBH |
| 17619958 | IMMUNE CELL SIGNATURE FOR BACTERIAL SEPSIS | Final Rejection | The General Hospital Corporation |
| 17770447 | METHOD FOR SEPARATING AND DETECTING EXOSOMES, AND KIT FOR SEPARATION AND DETECTION THEREOF | Non-Final OA | KEIO UNIVERSITY |
| 17575120 | S100A9 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS | Final Rejection | Roche Diagnostics Operations, Inc. |
| 17637098 | SCALED-UP METHODS FOR PURIFYING ANTIBODIES | Final Rejection | Yeda Research and Development Co. Ltd. |
| 17614563 | ARTIFICIAL RECEPTORS, RECOMBINANT CELLS COMPRISING THEREOF, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF | Final Rejection | YEDA RESEARCH AND DEVELOPMENT CO. LTD. |
| 18104055 | NPERSEVERE: BIOMARKERS ESTIMATING BASELINE MORTALITY RISK FOR NEONATAL SEPSIS AND NECROTIZING ENTEROCOLITIS | Non-Final OA | Children's Hospital Medical Center |
| 17638501 | KIT AND METHOD FOR CAPTURING A MOLECULE WITH MAGNETIC MEANS | Non-Final OA | INSTITUT POLYTECHNIQUE DE GRENOBLE |
| 17927648 | MACHINE READABLE DIAGNOSTIC TESTS AND METHODS AND APPARATUS TO MAKE AND/OR PROCESS THE SAME | Non-Final OA | Abbott Rapid Diagnostics International Unlimited Company |
| 17610044 | MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS | Non-Final OA | QUEST DIAGNOSTICS INVESTMENTS LLC |
| 17636755 | SYSTEMS AND METHODS FOR MENSTRUAL CYCLE TESTING | Non-Final OA | MFB Fertility, Inc. |
| 17795513 | DIAGNOSTIC REAGENT FOR QUANTITATIVE DETERMINATION OF PROCALCITONIN IN A SAMPLE | Non-Final OA | DiaSys Diagnostic Systems GmbH |
| 17747590 | METHOD FOR MEASURING BETA-1,3-1,6-GLUCAN | Final Rejection | Tokyo University of Pharmacy & Life Sciences |
| 17753884 | IMMUNOASSAY ANALYZER, IMMUNOASSAY KIT AND METHOD FOR DETECTING ANALYTE IN LIQUID SAMPLE | Non-Final OA | MOMM DIAGNOSTICS GMBH |
| 17634164 | METHOD OF IDENTIFYING PEPTIDE ANTIGENS AND USES THEREOF | Non-Final OA | HUMANIRAS UNIVERSITY |
| 17616117 | PROXIMITY-BASED LABELING SYSTEMS AND APPLICATIONS THEREOF | Final Rejection | MRL CAMBRIDGE ESC |
| 17459780 | PROTEIN ANTIGEN COMBINATION, DETECTION METHOD AND TESTING KIT USING THE SAME | Non-Final OA | SHANGHAI ZHONGQI BIOTECHNOLOGY CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy